Annual Securities Report — FY2025
What JMDC Inc. reported for the period from 2025-04-01 to 2026-03-31.
Filed 2026-06-24View the original on EDINET
How much it says
45Typical
What moved here
9named for the first time
Its own wording
45terms
Which filing this is
21/ 21newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the consolidated fiscal year ended 31 March 2026 (1 April 2025 to 31 March 2026), revenue, operating profit, and EBITDA increased, and both the Health Big Data and Telemedicine segments expanded. In addition, the transfer of all shares in ノアメディカル was completed in February 2025, and its pharmaceutical dispensing pharmacy support business has been treated as a discontinued operation.
Komori's summary of this document, not the document's own words.45Typical
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
40
Thin
52
Typical
75
Very detailed
0
Almost nothing
0
Almost nothing
55
Typical
13
Almost nothing
79
Very detailed
73
Detailed
R&D spend13億円Money spent making new things.
Cash left over-20億円Cash from the business, less what went into equipment.
Spent on equipment38億円Plants, machines — things meant to last.
Employees2,444Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.